Pharma’s Almanac, The Next-Generation Issue, Q2 2018

Direct-to-Patient (DTP) clinical trials are rapidly becoming the industry standard, with many trials underway today offering DTP options.
Comprehensive support of these complex trials requires a logistics provider with the expertise, resources and network to safeguard the entire supply chain — from the manufacturing point-of-origin through the last mile. The right global partner can minimize risk and eliminate inefficiencies associated with the management of constantly evolving, next-generation studies.